[go: up one dir, main page]

KR930703439A - Homologs of acidic fibroblast growth factor (aFGF) and wound treatment method - Google Patents

Homologs of acidic fibroblast growth factor (aFGF) and wound treatment method

Info

Publication number
KR930703439A
KR930703439A KR1019930701853A KR930701853A KR930703439A KR 930703439 A KR930703439 A KR 930703439A KR 1019930701853 A KR1019930701853 A KR 1019930701853A KR 930701853 A KR930701853 A KR 930701853A KR 930703439 A KR930703439 A KR 930703439A
Authority
KR
South Korea
Prior art keywords
afgf
homologs
growth factor
treatment method
fibroblast growth
Prior art date
Application number
KR1019930701853A
Other languages
Korean (ko)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR930703439A publication Critical patent/KR930703439A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019930701853A 1990-12-18 1993-06-17 Homologs of acidic fibroblast growth factor (aFGF) and wound treatment method KR930703439A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63245690A 1990-12-18 1990-12-18
PCT/US1991/009441 WO1992011360A1 (en) 1990-12-18 1991-12-17 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity

Publications (1)

Publication Number Publication Date
KR930703439A true KR930703439A (en) 1993-11-30

Family

ID=24535601

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930701853A KR930703439A (en) 1990-12-18 1993-06-17 Homologs of acidic fibroblast growth factor (aFGF) and wound treatment method

Country Status (9)

Country Link
EP (1) EP0575339A4 (en)
JP (1) JPH06503962A (en)
KR (1) KR930703439A (en)
AU (1) AU663067B2 (en)
CA (1) CA2098484A1 (en)
IE (1) IE914393A1 (en)
IL (1) IL100418A0 (en)
NZ (1) NZ241021A (en)
WO (1) WO1992011360A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717495B1 (en) * 1994-03-18 1996-04-12 Rhone Poulenc Rorer Sa Recombinant viruses, preparation and use in gene therapy.
CN1169158A (en) * 1994-10-13 1997-12-31 安姆根有限公司 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity
SI0785949T1 (en) * 1994-10-13 2003-08-31 Amgen Inc. Method for purifying keratinocyte growth factors
JP2733207B2 (en) * 1995-05-18 1998-03-30 工業技術院長 Pharmaceutical composition containing fibroblast growth factor chimeric protein
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
US7125856B1 (en) 1999-04-15 2006-10-24 St. Elizabeth's Medical Center Of Boston, Inc. Angiogenic growth factors for treatment of peripheral neuropathy
CA2365434A1 (en) * 1999-04-15 2000-10-26 St. Elizabeth's Medical Center Of Boston Angiogenic growth factors for treatment of peripheral neuropathy
US20070134204A1 (en) * 2005-12-09 2007-06-14 Henrich Cheng Method for treating nerve injury and vector construct for the same
US20100286042A1 (en) * 2007-10-12 2010-11-11 National Institute Of Advanced Industrial Science And Technology Medicinal Composition Containing Highly Functionalized Chimeric Protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000198A1 (en) * 1987-07-07 1989-01-12 Biotechnology Research Associates, J.V. Recombinant fibroblast growth factors
EP0241136A3 (en) * 1986-03-07 1989-12-27 The President And Fellows Of Harvard College Human class 1 heparin-binding growth factor
NZ226543A (en) * 1987-10-22 1992-02-25 Merck & Co Inc Recombinant mutant acidic fibroblast growth factor
DE3909009A1 (en) * 1989-03-18 1990-09-20 Schloemann Siemag Ag CONTINUOUS CASTING SYSTEM FOR CASTING PROFILES

Also Published As

Publication number Publication date
IE914393A1 (en) 1992-07-01
EP0575339A1 (en) 1993-12-29
IL100418A0 (en) 1992-09-06
NZ241021A (en) 1993-12-23
WO1992011360A1 (en) 1992-07-09
CA2098484A1 (en) 1992-06-19
AU663067B2 (en) 1995-09-28
EP0575339A4 (en) 1995-04-05
AU9152491A (en) 1992-07-22
JPH06503962A (en) 1994-05-12

Similar Documents

Publication Publication Date Title
DK0646012T3 (en) Wound healing and treatment of fibrotic diseases by TGFbeta-3
IL100181A0 (en) Method and apparatus for the treatment of skin wounds
FI942937L (en) Porous shaped delivery devices and method for making them
NZ227429A (en) Wound healing composition comprising purified platelet-derived growth factor and purified transforming growth factor alpha and method of use
FI941133L (en) Composition and method for treating hepatitis C
IS3949A (en) Analogous method of producing salt of lysine and N, N'-diacetylcysteine
EP0521591A3 (en) Light polarizer and method of manufacture
NO920867L (en) FACTOR CONCENTRATE AND PROCEDURE FOR ITS MANUFACTURING
DK0445255T3 (en) Treatment of conditions and illness
NO932996L (en) Exterior catheter, applicator and method of use
KR930703439A (en) Homologs of acidic fibroblast growth factor (aFGF) and wound treatment method
DE69118118D1 (en) Method and system for speech recognition without influencing noise
DE69133492D1 (en) Recombinant human hepatocyte growth factor and method for its production
NO921834L (en) PAIN REGULATORY COMPOSITION AND PROCEDURE FOR MANUFACTURING
HU9302183D0 (en) Medical preparatives for preventing and treating osteoporises after menopausa
ITMI912470A0 (en) NOZZLE AND YARN TREATMENT METHOD
EP0527783A4 (en) Method of treatment with hsp70
EP0494995A4 (en) Method of accelerating wound and ulcer healing and treating periodontal disease
MX9200040A (en) GROWTH FACTOR OF THE RECOMBINANT BASIC HUMAN FIBROBLAST AND METHOD FOR OBTAINING IT.
HU904133D0 (en) Apparatus for treating patients with magnetic alpha walves and pulsating magnetic space
RU1827261C (en) Method of wound treatment
SE9004160D0 (en) METHOD OF TREATING PAIN
FI940252A (en) Method and apparatus for reducing skin tissue
FI91027C (en) Pattern recognition method and system
GB9027581D0 (en) Method of identification of sites of inflammation or infection

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930617

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19961217

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930617

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19990126

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19990330

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19990126

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I